- Home
- SITE vs DNTH Comparison
SITE vs DNTH Comparison
Compare SITE & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SITE | DNTH |
|---|---|---|
| Founded | 2001 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional and commerical equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.6B |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SITE | DNTH |
|---|---|---|
| Price | $125.23 | $88.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $160.38 | $121.00 |
| AVG Volume (30 Days) | ★ 722.6K | 523.2K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.35 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,704,800,000.00 | $2,036,000.00 |
| Revenue This Year | $6.78 | N/A |
| Revenue Next Year | $4.08 | $29.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $112.23 | $16.77 |
| 52 Week High | $168.56 | $96.50 |
Technical Indicators
Market Signals| Indicator | SITE | DNTH |
|---|---|---|
| Relative Strength Index (RSI) | 38.28 | 56.27 |
| Support Level | $123.64 | $33.94 |
| Resistance Level | $142.22 | $96.50 |
| Average True Range (ATR) | 6.65 | 4.02 |
| MACD | -2.02 | -1.21 |
| Stochastic Oscillator | 21.50 | 45.82 |
Price Performance
Historical ComparisonAbout SITE SiteOne Landscape Supply Inc.
SiteOne Landscape Supply Inc is a supplier of tools and equipment. The company serves various businesses which include wholesale irrigation, outdoor lighting, nursery, landscape supplies, grass seeds, and fertilizers, turf protection products, turf care equipment, and golf course accessories for green industry professionals mainly in the United States and Canada. Its product portfolio includes irrigation supplies, fertilizer and herbicides, landscape accessories, nursery goods, natural stones and blocks, outdoor lighting and ice melt products and other products.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.